Product
HRS-2261
Aliases
HRS-2261 tablet、placebo
2 clinical trials
2 indications
Indication
Chronic CoughIndication
Refractory Chronic CoughClinical trial
Phase I Clinical Study on the Safety, Tolerability, and Pharmacokinetics of HRS-2261, the Effects of Food on the Pharmacokinetics of HRS-2261, and the Effects of HRS-2261 on CYP3A4 Metabolic Enzymes in Healthy Subjects After Single and Multiple Oral AdministrationStatus: Completed, Estimated PCD: 2022-10-25
Clinical trial
A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Study of Efficacy and Safety of HRS-2261 in Refractory Chronic CoughStatus: , Estimated PCD: 2024-03-30